优化剂量处方作为绿色连续脏替代疗法的第一步
Harin Rhee1,2,3, Taeil Kim3,4, Kyung Sook Jung3
1Department of Internal Medicine, Pusan National University School of Medicine, Busan, Republic of Korea.
Kidney medicine
|October 6, 2025
概括
优化持续置换疗法 (CKRT) 剂量可使流体消耗降低12.7%,而不会影响透析疗效. 这项研究表明,通过对CKRT进行剂量调整,可以显著节省液体.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 关键护理医学 关键护理医学
- 流体管理流体管理
背景情况:
- 持续置换疗法 (CKRT) 对重症患者至关重要,但往往需要大量的液体.
- 在CKRT中过度使用液体可能会导致浪费和潜在的并发症.
- 优化CKRT剂量对于平衡疗效和资源利用至关重要.
研究的目的:
- 评估优化CKRT剂量对流体消耗的影响.
- 评估剂量优化对透析疗效的影响.
- 为了确定CKRT剂量调整后生化参数的变化.
主要方法:
- 一个单一中心前性研究,涉及接受CKRT的患者.
- 将CKRT处方剂量从35-25-30毫升/千克/小时调整为20-25毫升/千克/小时,与KDIGO指南保持一致.
- 统计分析包括一般线性模型和反复测量ANOVA,以比较剂量优化前后的结果.
主要成果:
- 总共分析了441名患者 (210名前优化,231名后优化).
- 传递的中位数CKRT剂量显著下降 (P < 0.001),导致每人每天消耗液体减少6.7升 (P < 0.001).
- 生物化学参数变化 (血清尿素,肌,,酸盐,碳酸盐) 在优化后没有显著差异.
结论:
- 优化CKRT剂量有效地减少了大约12.7% (6.7L/人/天) 的流体消耗.
- 这种剂量优化策略保持了治疗疗效.
- 进一步的研究可能会根据患者的人口统计数据 (如体重) 探索节水效应的变化.
相关概念视频
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
208
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
208
01:11Renal Failure: Dose Adjustments
437
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
437
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
189
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
189
01:30Continuous Renal Replacement Therapy
831
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
831
01:20Acute Kidney Injury V: Interprofessional Care
296
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
296
01:28Chronic Kidney Disease III: Interprofessional Care
339
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
339